Structure-activity relationships of some taxoids as multidrug resistance modulator

被引:7
|
作者
Hasegawa, Toshiaki
Bai, Jao
Zhang, Shujun
Wang, Jinlan
Matsubara, Junichi
Kawakami, Junichi
Tomida, Akihiro
Tsuruo, Takashi
Hirose, Katsutoshi
Sakai, Junichi
Kikuchi, Midori
Abe, Mariko
Ando, Masayoshi
机构
[1] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan
[2] Niigata Univ, Dept Chem & Chem Engn, Fac Engn, Niigata 9502181, Japan
[3] Mitsubishi Gas Chem Co Inc, Niigata Res Lab, Niigata 9503112, Japan
[4] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan
[5] Kobe Nat Prod & Chem Co Ltd, Kanzaki, Hyogo 6792315, Japan
关键词
taxoid; taxinine; 1,7-deoxy-4-deacetylbaccatin III; MDR; cytotoxicity;
D O I
10.1016/j.bmcl.2006.09.068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1,7-Deoxy-4-deacetylbaccatin III (12) and its five analogues 6-9, 13, and their oxetane ring opened derivatives 14, 16, and 17, which were synthesized from taxinine, showed significant activity as MDR reversal agent by the assay of the calcein accumulation toward MDR human ovarian cancer 2780AD cells. The most effective compound 12 in this assay is actually efficient for the recovery of cytotoxic activity of paclitaxel (taxol), adriamycin (ADM), and vincristine (VCR) toward MDR 2780AD cells at the same level toward parental 2780 cells. This activity of 12 is very interesting because baccatin 111 (4) has no such MDR reversal activity but has cytotoxic activity. The essential functional groups inducing such a difference in biological activity between 4 and 12 are 4 alpha-acetoxyl for 4 and 4 alpha-hydroxyl for 12. In seven compounds possessing MDR reversal activity, compound 12 is the most desirable compound for anti-MDR cancer reversal agent, because it has the highest accumulation ability of anticancer agent in MDR cancer cells and weak cytotoxic activity. Compounds 8 and 13 showed significant cytotoxic activity toward HepG2 and VA-13, respectively, as well as MDR reversal activity. They are expected to become lead compounds for new types of anticancer agent or anti-MDR cancer agent. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1122 / 1126
页数:5
相关论文
共 50 条
  • [1] Structure-activity relationships of multidrug resistance reversers
    Wiese, M
    Pajeva, IK
    CURRENT MEDICINAL CHEMISTRY, 2001, 8 (06) : 685 - 713
  • [2] Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells
    Hasegawa, Toshiaki
    Bai, Jiao
    Dai, Jungui
    Bai, Liming
    Sakai, Junichi
    Nishizawa, Shigenori
    Bai, Yuhua
    Kikuchi, Midorl
    Abe, Mariko
    Yamori, Takao
    Tomida, Akihiro
    Tsuruo, Takashi
    Hirose, Katsutoshi
    Ando, Masayoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) : 3722 - 3728
  • [3] Structure-Activity Relationships of Tariquidar Analogs as Multidrug Resistance Modulators
    Pajeva, Ilza K.
    Wiese, Michael
    AAPS JOURNAL, 2009, 11 (03): : 435 - 444
  • [4] Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators
    Globisch, C
    Pajeva, IK
    Wiese, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (05) : 1588 - 1598
  • [5] General and recent aspects of the chemistry and structure-activity relationships of taxoids
    Guéritte, F
    CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (13) : 1229 - 1249
  • [6] Jatrophanes as promising multidrug resistance modulators: Advances of structure-activity relationships
    Li, Jun
    Wang, Wen-qiong
    Tang, Shuai
    Song, Wei-bin
    Xuan, Li-jiang
    FITOTERAPIA, 2018, 127 : 138 - 145
  • [7] Multidrug resistance modifiers: Structure-activity relationships and molecular modeling study
    Pajeva, IK
    Wiese, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R394 - R394
  • [8] P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS
    Huber, Paula C.
    Maruiama, Cintia H.
    Almeida, Wanda P.
    QUIMICA NOVA, 2010, 33 (10): : 2148 - 2154
  • [9] Structure-activity relationships of taxoids:: a molecular descriptors family approach
    Bolboaca, Sorana D.
    Jantschi, Lorentz
    ARCHIVES OF MEDICAL SCIENCE, 2008, 4 (01) : 7 - 15
  • [10] Synthesis and structure-activity relationships of new second-generation taxoids
    Ojima, I
    Wang, T
    Miller, ML
    Lin, SN
    Borella, CP
    Geng, XD
    Pera, P
    Bernacki, RJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (24) : 3423 - 3428